LOWENCO develops, manufactures, markets, and installs large-scale modular and highly energy-efficient ultra-low temperature (ULT) storage solutions for the biotech and pharmaceutical industry, primarily targeting the drug substance market.

LOWENCO has developed a sustainable cold storage solution, an alternative to traditional upright freezers.

Mikael Hoier, CEO of LOWENCO A/S, states
“LOWENCO is an acronym for Low Energy Cooling. In every product we are developing – saving energy is essential – without any reflection on the quality and performance. We want to help make the world a better place to live. Every time we can replace existing solutions used in the market with our innovative solutions with lower energy consumption, we are helping to reduce the CO2 footprint.
Human-induced climate change is an unprecedented challenge and a global problem like no other that humanity has faced. The actions we take today will decide the future of our children and the generations that follow them. A LOWENCO product ensures absolute minimum impact on the environment by reducing the carbon footprint by 60%.”

LOWENCO was founded in 2013 in Vamdrup, Denmark. Following an initial period of product refinement and establishment of go-to-market activities, LOWENCO has gained significant commercial traction over the past years and is today a preferred supplier of sustainable large-scale modular ULT storage solutions to several of the largest biotech and pharmaceutical companies across the globe.